Arca
Skip to content

Piccolo Metlyte 7 Reagent Disc

Atp And Creatine Kinase (Enzymatic), Creatine. 510(k) K992140, from Abaxis, Inc. (Sunnyvale, CA). Product code JLB, class 1.

As of Nov 17, 2026, K992140 is an FDA 510(k) held by Abaxis, Inc., substantially equivalent on Aug 26, 1999 after 63 days, with 2 recalls tied to it in FDA's recall database.

  • Substantially equivalent: Aug 26, 1999
  • Review time: 63 days
  • Recalls: 2
  • Cited as a predicate by: 1 device

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

Creatine Kinase The creatine kinase assay is used for the quantitation of creatine kinase in human heparinized whole blood, heparinized plasma, or serum. Measurements of creatine kinase and its isoenzymes are used in the diagnosis and treatment of myocardial infarction, progressive muscular dystrophy, dermatomyositis, rhabdomyolysis due to drug ingestion, hyperosmolality, autoimmune disease…

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

1 later 510(k) summary names this device as a predicate

Recalls

Recalls FDA ties to K992140, newest first; each opens FDA's recall record
Apr 21, 2008Z-2286-2008The product will recover tCO2 at approximately 5-7 units high relative to some controls and patient samplesTerminated
Apr 21, 2008Z-2287-2008The product will recover tCO2 at approximately 5-7 units high relative to some controls and patient samplesTerminated

Record

Type
Traditional
Received
Jun 24, 1999
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1210

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.